|
LDHB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.22124532708767E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.35553848332893E-13 |
| Normal-vs-Stage2 |
1.160220E-01 |
| Normal-vs-Stage3 |
3.02025071619028E-12 |
| Normal-vs-Stage4 |
2.99760216648792E-15 |
| Stage1-vs-Stage2 |
3.118200E-03 |
| Stage1-vs-Stage3 |
8.108100E-02 |
| Stage1-vs-Stage4 |
6.34800000000046E-05 |
| Stage2-vs-Stage3 |
2.631400E-04 |
| Stage2-vs-Stage4 |
1.14909999959778E-07 |
| Stage3-vs-Stage4 |
1.801780E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.352170E-04 |
| Normal-vs-Asian |
2.97010000038789E-07 |
| Caucasian-vs-AfricanAmerican |
7.745000E-01 |
| Caucasian-vs-Asian |
4.808000E-01 |
| AfricanAmerican-vs-Asian |
4.685000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.93149940486137E-11 |
| Normal-vs-Female |
1.63569158218024E-12 |
| Male-vs-Female |
5.372800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.83428835956556E-12 |
| Normal-vs-Age(41-60Yrs) |
2.24265050974282E-14 |
| Normal-vs-Age(61-80Yrs) |
3.37919999982006E-07 |
| Normal-vs-Age(81-100Yrs) |
1.239680E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.949600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.301600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.364200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.724600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.064200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.625800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.32870000005381E-06 |
| Classical-VS-Follicular |
6.04220007360823E-11 |
| Classical-VS-Other |
3.273000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.62458935193399E-12 |
| Tall-VS-Other |
7.941800E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.545020E-01 |
| Follicular-VS-Normal |
8.634400E-01 |
| Other-VS-Normal |
1.423570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.73200001405161E-09 |
| Normal-vs-N1 |
1.62725388719309E-12 |
| N0-vs-N1 |
1.86413999999635E-05 |
|
|
